Non-small cell lung cancer the consensus of postoperative adjuvant chemotherapy.doc

 PAGE \* MERGEFORMAT 6 Non-small cell lung cancer the consensus of postoperative adjuvant chemotherapy [Abstract] In recent years the non-small cell lung cancer after standard adjuvant chemotherapy for the treatment of significant changes have taken place, more and more forward-looking, large sample randomized clinical trials and several meta-analysis have confirmed that adjuvant chemotherapy, in particular, the new generation of chemotherapy platinum-containing drugs, a joint program can significantly increase response to chemotherapy and overall survival, reduce the risk of death ratio, and the toxicity can be tolerated. Therefore, for a complete post-operative non-small cell lung cancer, especially Ⅰ B ~ Ⅱ phase were treated with adjuvant chemotherapy is a reasonable treatment. [Keywords:] non-small cell lung cancer adjuvant chemotherapy Postoperative Adjuvant Chemotherapy for Non-Small Cell Lung Cancer Abstract: Recently the standard of postoperative adjuvant chemotherapy for non-small cell lung cancer has significantly changed.More and more large scale and prospective randomized clinical trials and Meta-analyses have proved that adjuvant chemotherapy, especially new generation of chemotherapeutic agents combined with platinum can significantly improve the median and overall survival. It also can decrease the hazard ratio for death and its toxicity is tolerable.Therefore adjuvant chemotherapy is a optimal therapy for patients with non-small cell lung cancer completely resected, especially in stage Ⅰ B and Ⅱ . Keywords:: non-small cell lung cancer; adjuvant chemotherapy Of lung cancer on the growing threat to human health, lung cancer incidence, mortality increased significantly in 2002, the world’s 135 million new cases of lung cancer-related deaths due to 1.18 million [1]. Non-small cell lung cancer is lung cancer, the most common type, accounting for 80% of lung cancer 85%, surgical resection is the treatment of operable non-small cell lung cance